Molecular Partners Stock Quote MOLN - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

4.87

Bid

2.50

Ask

7.20

Volume

17,413

4.82 Day's Range 5.3445

0.00 52 Week Range 0.00

Market Cap

177.045M

Previous Close

4.98

Open

5.02

Last Trade

4.79

Last Trade Time

Financial Volume

$ 91,891

VWAP

5.2771

Average Volume (3m)

Shares Outstanding

36,354,297

Dividend Yield

PE Ratio

-14.78

Earnings Per Share (EPS)

-1.71

Revenue

7.04M

Net Profit

-61.98M

Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseas... Molecular Partners AG is a clinical stage biopharmaceutical company. The company focuses on the discovery, development and prospective commercialization of a new class of biopharmaceutical products. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.molecularpartners.com

Headquarters

Schlieren, Che

Founded

Molecular Partners AG is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker MOLN. The last closing price for Molecular Partners was $4.98. Over the last year, Molecular Partners shares have traded in a share price range of $ 0.00 to $ 0.00.

Molecular Partners currently has 36,354,297 shares outstanding. The market capitalization of Molecular Partners is $181.04 million. Molecular Partners has a price to earnings ratio (PE ratio) of -14.78.

Molecular Partners Announces upcoming poster presentations at the 2024 SITC Annual Meeting

Preclinical proof-of-concept data supports CD3 Switch-DARPin platform for T cell engagers with enhanced function in solid tumors Biomarker data on completed phase 1 study of MP0317 (FAP x CD40...

Molecular Partners Announces Upcoming Top-Rated Oral Presentation on MP0712, a ²¹²Pb-labeled Radio-DARPin Therapeutic targeting DLL3 for Small Cell Lung Cancer co-developed with Orano Med, at EANM 2024

First RDT candidate MP0712 shows low kidney accumulation and high tumor uptake in preclinical models MP0712 treatment leads to strong tumor growth inhibition with a good safety profile in vivo...

Molecular Partners and Orano Med Share Positive Preclinical Data of their DLL3-Targeting Radio-DARPin Therapy (RDT) Candidate MP0712 at SNMMI 2024

MP0712, a 212Pb-Radio-DARPin targeting DLL3, as first candidate of Molecular Partners’ RDT platform in development in partnership with Orano MedPositive tumor to kidney ratio and biodistribution...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DR
4	0	0	0	0	0	0	0	DR
12	0	0	0	0	0	0	0	DR
26	0	0	0	0	0	0	0	DR
52	0	0	0	0	0	0	0	DR
156	0	0	0	0	0	0	0	DR
260	0	0	0	0	0	0	0	DR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DRUGBright Minds Biosciences Inc	$ 47.37 (118.29%)	27.24M
BIVIBioVie Inc	$ 2.3304 (108.07%)	52.3M
HEPSD Market Electronic Services and Trading	$ 3.52 (60.00%)	43.86M
LTBRLightbridge Corporation	$ 6.98 (56.85%)	7.72M
PEGYPineapple Energy Inc	$ 8.19 (48.64%)	31.69M
NKGNNKGen Biotech Inc	$ 0.3974 (-43.23%)	5.06M
ORGSOrgenesis Inc	$ 2.1001 (-35.14%)	486.29k
BIAFbioAffinity Technologies Inc	$ 1.40 (-34.27%)	1.45M
VEVVicinity Motor Corporation	$ 0.0466 (-31.27%)	37.52M
CETXCemtrex Inc	$ 0.299 (-27.07%)	20.69M
JTAIJet AI Inc	$ 0.1008 (4.02%)	347.49M
NVDANVIDIA Corporation	$ 138.00 (0.78%)	175.79M
SQQQProShares UltraPro Short QQQ	$ 7.13 (-1.79%)	105.78M
TVGNTevogen Bio Holdings Inc	$ 1.72 (24.64%)	101.27M
LCIDLucid Group Inc	$ 2.625 (-2.42%)	80.88M